Compositions and methods of mRNA vaccines against novel coronavirus infection

Provided herein is a ribonucleic acid (RNA) encoding a spike (S) protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), or an immunogenic fragment thereof, the spike (S) protein or the immunogenic fragment thereof comprising at least one non-naturally occurring amino acid mutation....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ANANTHASWAMY NITHSH, SHEN DONG, BROWN DAVID, JEON JOO-HYUNG, LU CHUN, TANG SHENGGAO, BONG, YOUNG-SIK, HE JIAXI, CHEN RENXIANG, HE ZIYANG, LONG ZHIFENG, LU, PATRICK, Y
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Provided herein is a ribonucleic acid (RNA) encoding a spike (S) protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), or an immunogenic fragment thereof, the spike (S) protein or the immunogenic fragment thereof comprising at least one non-naturally occurring amino acid mutation. In some embodiments, the S protein is derived from a delta variant. Related polynucleotides, vectors, cells, compositions, kits, methods of production, and methods of use are also provided. 本文提供了编码严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的刺突(S)蛋白或其免疫原性片段的核糖核酸(RNA),该刺突(S)蛋白或其免疫原性片段包含至少一个非天然存在的氨基酸突变。在一些实施方案中,该S蛋白来源于δ变体。另外提供了相关的多核苷酸、载体、细胞、组合物、试剂盒、生产方法和使用方法。